4/A
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-035849
Options or other derivatives
- Senior Vice President and CFO acquired 127,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-12-17 | Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) | +127,000 | 127,000 | D |
Loading xslF345X03/form4a.xml…